(The AEGIS Alliance) – A brand new male birth control pill method has been discovered to be 99 percent successful when evaluated in mice, a research study showed at a Wednesday conference of the American Chemical Society (ACS).
Gunda Georg, a medical chemist that leads the University of Minnesota laboratory performing the study pointed out that human trials of the nonhormonal birth control method for males may potentially start as quickly as the 3rd or 4th quarter of 2022, a news release from the ACS noted.
“Scientists have been trying for decades to develop an effective male oral contraceptive,” claimed Abdullah Al Noman, a graduate student associated with the study.
Currently, no authorized male contraception in pill form is on the market, Noman stated.
The ACS took note that most male contraceptive pills in development utilize bodily hormones to target testosterone levels, which can possibly trigger side effects including bodyweight increase, depression, as well as raised low-density lipoprotein cholesterol amounts.
“We wanted to develop a non-hormonal male contraceptive to avoid these side effects,” Noman mentioned.
When provided by mouth to male mice for 4 full weeks, the substance scientists evaluated was actually discovered to be 99 percent successful in preventing pregnancy in female mice. No evident side effects were found, and male mice had the ability to reproduce within 4 to 6 weeks after they stopped taking the substance.
“Because it can be difficult to predict if a compound that looks good in animal studies will also pan out in human trials, we’re currently exploring other compounds, as well,” Gunda Georg noted.
Kyle James Lee – The AEGIS Alliance – This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
